{"id":392074,"date":"2020-12-02T14:42:11","date_gmt":"2020-12-02T19:42:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=392074"},"modified":"2020-12-02T14:42:11","modified_gmt":"2020-12-02T19:42:11","slug":"shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/","title":{"rendered":"SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WILMINGTON, Del., Dec.  02, 2020  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LQTiFhsFtQjqjrK5TDUk0m8ga1xygezJE7gf8cDixmboXzoOsn70LtykiO68nOSw5PYabP5M-xM96IRyo6bi-TAFVwjs18BepBRqATdxKUk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Rigrodsky &amp; Long, P.A.<\/a> announces that it is investigating BridgeBio Pharma, Inc. (\u201cBridgeBio\u201d) (NASDAQ GS: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QC5EsoX8MsxB34alhSqCLhJz5Oo-ydinrPG-yEOhyu_g-LxPxZ7zKAkjKvYzablLs5Im5Cb__H973nBCJ9Wycssx5ZGcIHf6qFDg-ABq7f4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">BBIO<\/a>) regarding possible breaches of fiduciary duties and other violations of law related to BridgeBio\u2019s agreement to merge with Eidos Therapeutics, Inc. (\u201cEidos\u201d). Under the terms of the agreement, BridgeBio will issue either $73.26 in cash or 1.85 shares of BridgeBio common stock to shareholders of Eidos.<\/p>\n<p>To learn more about this investigation and your rights, visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rfi6SsYFZu_pMpsi01F2qGegd3mvuxXWJYNyTwdAexkQLFBz6hW5I7mYYmJuoTXDPTvbyKr0DSUpz3fj24O2HIZvyc0UK_KVyXXHNrfmmZR29j1rY6pangwc6AhzLAtYWhiAB5SUFrNlocvmv4joYdAVu1lG5EoI83WmfxU3-tU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.rl-legal.com\/cases-bridgebio-pharma-inc<\/a>.<\/p>\n<p align=\"justify\">You may contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GYvoIx8Uzb1HOf77edqWjJeCC2wCktxzeS_ZCNR8OduyIRChiQ49-UHyISz64X4z3IvwMYczne3tjFBLyqL3rQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@rl-legal.com<\/a>.<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LQTiFhsFtQjqjrK5TDUk0m8ga1xygezJE7gf8cDixmabsK4YRwC1QsAnnFO73dCVLipTuxpqnYHd8JdgMQIo-fv27PORSyxo3QLCSvxVZn8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Rigrodsky &amp; Long, P.A.<\/a>, with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OsGVToWpmwPNDLUNZN4tzZvcSsHjbRy7j68IHBl9cmOZoSgzRW4g46tsR1rR8ez3Sfl-4HBvmtBR10oCwT5lSz00vflW7TW5DaxiKUSspTA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">securities fraud <\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uXyV9R5ES4CkHOtDUpP0bI7_t6a-7t7-4HESUc_rgO5PiORT7IY_WnooBIV30lqMubB53WwxEfMsXSN0RSVe5EQZtWtDAUSdQBOvufSGG4ukSAkEsSxzYiXada0Brz8D\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">and corporate class <\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8LMcl7u7tZtEJDZ_MBOROI-yzYtboiiUZXr375COBjha_LdzYj8D3dV93myYrnrniE4WdwPNPd4Mwh7tftoQrIyvEp5qolmoT1iVk-xrY1o=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">actions<\/a> nationwide.<\/p>\n<p>Attorney advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p>CONTACT:<\/p>\n<p>Rigrodsky &amp; Long, P.A.<br \/>Seth D. Rigrodsky<br \/>Gina M. Serra<br \/>(888) 969-4242 (Toll Free)<br \/>(302) 295-5310<br \/>Fax: (302) 654-7530<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GYvoIx8Uzb1HOf77edqWjGLoibnV6hBWJ4ZfwcoV3UOD7LHDXu2QTHHMzyDf3cZfoTW6O6clM9UHpjda3jZrJQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@rl-legal.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rfi6SsYFZu_pMpsi01F2qJdxLwhXqyR0YFcsA7wxeQIi2FC3Bn3Zs3jZVMDK64Ekvmnddw4pWnprTCt2P_JDng==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/rl-legal.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTc0MCMzODUzNTg1IzIwMjg5Nzc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/68dfe006-b736-4354-85ca-0753239d2cff\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WILMINGTON, Del., Dec. 02, 2020 (GLOBE NEWSWIRE) &#8212; Rigrodsky &amp; Long, P.A. announces that it is investigating BridgeBio Pharma, Inc. (\u201cBridgeBio\u201d) (NASDAQ GS: BBIO) regarding possible breaches of fiduciary duties and other violations of law related to BridgeBio\u2019s agreement to merge with Eidos Therapeutics, Inc. (\u201cEidos\u201d). Under the terms of the agreement, BridgeBio will issue either $73.26 in cash or 1.85 shares of BridgeBio common stock to shareholders of Eidos. To learn more about this investigation and your rights, visit: https:\/\/www.rl-legal.com\/cases-bridgebio-pharma-inc. You may contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com. Rigrodsky &amp; Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-392074","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WILMINGTON, Del., Dec. 02, 2020 (GLOBE NEWSWIRE) &#8212; Rigrodsky &amp; Long, P.A. announces that it is investigating BridgeBio Pharma, Inc. (\u201cBridgeBio\u201d) (NASDAQ GS: BBIO) regarding possible breaches of fiduciary duties and other violations of law related to BridgeBio\u2019s agreement to merge with Eidos Therapeutics, Inc. (\u201cEidos\u201d). Under the terms of the agreement, BridgeBio will issue either $73.26 in cash or 1.85 shares of BridgeBio common stock to shareholders of Eidos. To learn more about this investigation and your rights, visit: https:\/\/www.rl-legal.com\/cases-bridgebio-pharma-inc. You may contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com. Rigrodsky &amp; Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf &hellip; Continue reading &quot;SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-02T19:42:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTc0MCMzODUzNTg1IzIwMjg5Nzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger\",\"datePublished\":\"2020-12-02T19:42:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\\\/\"},\"wordCount\":187,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTc0MCMzODUzNTg1IzIwMjg5Nzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\\\/\",\"name\":\"SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTc0MCMzODUzNTg1IzIwMjg5Nzc=\",\"datePublished\":\"2020-12-02T19:42:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTc0MCMzODUzNTg1IzIwMjg5Nzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTc0MCMzODUzNTg1IzIwMjg5Nzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/","og_locale":"en_US","og_type":"article","og_title":"SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger - Market Newsdesk","og_description":"WILMINGTON, Del., Dec. 02, 2020 (GLOBE NEWSWIRE) &#8212; Rigrodsky &amp; Long, P.A. announces that it is investigating BridgeBio Pharma, Inc. (\u201cBridgeBio\u201d) (NASDAQ GS: BBIO) regarding possible breaches of fiduciary duties and other violations of law related to BridgeBio\u2019s agreement to merge with Eidos Therapeutics, Inc. (\u201cEidos\u201d). Under the terms of the agreement, BridgeBio will issue either $73.26 in cash or 1.85 shares of BridgeBio common stock to shareholders of Eidos. To learn more about this investigation and your rights, visit: https:\/\/www.rl-legal.com\/cases-bridgebio-pharma-inc. You may contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com. Rigrodsky &amp; Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf &hellip; Continue reading \"SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-02T19:42:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTc0MCMzODUzNTg1IzIwMjg5Nzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger","datePublished":"2020-12-02T19:42:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/"},"wordCount":187,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTc0MCMzODUzNTg1IzIwMjg5Nzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/","name":"SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTc0MCMzODUzNTg1IzIwMjg5Nzc=","datePublished":"2020-12-02T19:42:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTc0MCMzODUzNTg1IzIwMjg5Nzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTc0MCMzODUzNTg1IzIwMjg5Nzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-rigrodsky-long-p-a-announces-investigation-of-bridgebio-pharma-inc-merger\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Announces Investigation of BridgeBio Pharma, Inc. Merger"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/392074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=392074"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/392074\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=392074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=392074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=392074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}